# A Clinical Study of GRC 8200 in Type 2 Diabetes Mellitus

> **NCT00836940** · PHASE2 · UNKNOWN · sponsor: **Glenmark Pharmaceuticals Europe Ltd. (R&D)** · enrollment: 480 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** GRC 8200

## Key facts

- **NCT ID:** NCT00836940
- **Lead sponsor:** Glenmark Pharmaceuticals Europe Ltd. (R&D)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-06
- **Primary completion:** 2009-05
- **Final completion:** 2009-10
- **Target enrollment:** 480 (ESTIMATED)
- **Last updated:** 2009-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00836940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00836940, "A Clinical Study of GRC 8200 in Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00836940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*